In response to its lagging stock, Allergan Plc (NYSE: AGN) will seek buyers for both its women’s health and infectious disease units. CEO Brett Saunders confirmed the unanimous board decision in an interview with Reuters on Wednesday.
Evolus Inc. (Nasdaq: EOLS) appointed Lauren Silvernail as chief financial officer and executive vice president of corporate development.
British engineering firm Smiths Group plc (LON: SMIN) confirmed it is in “very early stage discussions about a potential merger of its medical division with ICU Medical Inc. (Nasdaq: ICUI),” according to a company press release.
Annette Walker has been named president of City of Hope, Orange County, in charge of developing the cancer center planned for the Great Park Neighborhoods in Irvine.
Irvine-based Evolus Inc.’s stock (Nasdaq: EOLS) have taken a rollercoaster ride this week. Shares earlier buoyed by news of its new chief executive dove today when it gave updates related to the regulatory progress on the pending approval of its drug candidate DWP-450.
Allergan Plc named Carrie Strom as senior vice president of U.S. Medical Aesthetics, reporting to Chief Commercial Officer Bill Meury.
Evolus Inc. named David Moatazedi president and chief executive. He comes from Allergan plc, where he was most recently senior vice president of U.S. medical aesthetics.
Allergan PLC Chief Executive Brent Saunders told investors on Monday that the company is evaluating a range of strategic options, including “splitting the company.”
Judge Andrew Guilford ruled on Tuesday that the government can proceed with a third trial against health-care executive Jim Mazzo on insider trading charges.
Allergan Plc posted first quarter earnings that beat analyst estimates and raised its revenue guidance for 2018.
Lawyers came to Judge Andrew Guilford’s courtroom on Monday with two motions and three arguments to prevent a third trial against Jim Mazzo for breaking insider trading rules.
Children’s Hospital of Orange County plans to open an autism center at 170 S. Main St. in Orange in early 2019.
ChromaDex Corp. (Nasdaq: CDXC) said Chief Executive Frank Jaksch will become executive chairman and the company’s current president and chief operating officer, Rob Fried, will get Jaksch's role June 22, after the company’s annual meeting.
Allergan PLC won’t pursue a deal to buy Shire PLC, the company said, after earlier considering a bid.
HEALTHCARE: Launched IvyGene; to expand Irvine HQ
Irvine-based Laboratory for Advanced Medicine Inc. isn’t pursuing a magic-bullet immunotherapy drug to cure all cancers yet, but it sure is in growth mode.